Bendriss-Vermare, Nathalie
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Nathalie Bendriss-Vermare researcher
VIAF ID: 295514075 (Personal)
Permalink: http://viaf.org/viaf/295514075
Preferred Forms
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| Améliorer les effets anti-tumoraux des lymphocytes T folliculaires helper (Tfh) en ciblant la communication intercellulaire entre Tfh et Th2. |
|
| Analysis of the antiviral properties of the interleukin-26. |
|
| Analysis of the tumor microenvironment of ovarian cancers according to genomic instability. |
|
| BDCA1<sup>+</sup> cDC2s, BDCA2<sup>+</sup> pDCs and BDCA3<sup>+</sup> cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients |
|
| Bénéfice des modulateurs métaboliques en combinaison aux chimio-immunothérapies anticancéreuses |
|
| Benefit of Metabolic Modulators to the Efficiency of Antitumor Chemo-Immunotherapies. |
|
| Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1a(high)CD86(-)Langerin- and CD1a(+)CD86(+)Langerin+ phenotypes. |
|
| CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues |
|
| CD163+ tumor-associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes |
|
| CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer. |
|
| LES CELLULES DENDRITIQUES PLASMACYTOIDES HUMAINES : MISE EN EVIDENCE DE LEURS SPECIFICITES MOLECULAIRE ET FONCTIONNELLE |
|
| Characterization of Pattern Recognition Receptor Expression and Functionality in Liver Primary Cells and Derived Cell Lines |
|
| Characterization of the plasmacytoid dendritic cells activation by HTLV-1 or HTLV-2 and its importance on the viral-associated pathogenesis. |
|
| Characterization of the role of BAD-LAMP as a chaperone of "Toll like receptors" in human plasmacytoid dendritic cells. |
|
| Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer |
|
| Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80<sup>+</sup> PDL1<sup>-</sup>)-pDC subset negatively correlated with clinical outcomes in melanoma patients |
|
| Division of Labor Between Distinct Human Plasmacytoid Dendritic Cell Subsets Following Viral Activation |
|
| Durable and controlled depletion of neutrophils in mice |
|
| Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival |
|
| Etude du microenvironnement tumoral des cancers de l'ovaire en fonction de l'instabilité génomique |
|
| Génération de nanobodies pour des applications en immunothérapie |
|
| Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration |
|
| Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs |
|
| Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection |
|
| Human thymus contains IFN-α-producing CD11c–, myeloid CD11c+, and mature interdigitating dendritic cells |
|
| Human Tumor-Infiltrating Dendritic Cells: From in Situ Visualization to High-Dimensional Analyses |
|
| IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer |
|
| Impaired IFN- Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression |
|
| Improvement of the anti-tumoral effects of T follicular helper cells (Tfh) by the targeting of the intercellular cross-talk between Tfh and Th2 cells.. |
|
| The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12 |
|
| Inflammasome Deletion Promotes Anti-tumor NK Cell Function in an IL-1/IL-18 Independent Way in Murine Invasive Breast Cancer |
|
| Inflammasomes : from caspase-1 activation mechanisms to tumor progression. |
|
| Influence of the seminal plasma on HIV-1 sexual transmission mediated by dendritic cells. |
|
| Interaction between TLR9-CpG-ODNs and HBV virions leads to entry inhibition in hepatocytes and reduction of IFNα production by pDC. |
|
| L'interleukine-33 : de son expression dans le cancer du sein à l'activation des cellules NK |
|
| Liver X receptors as modulators of plasmacytoid dentritic cell functions and thier leukemic counterpart. |
|
| A Milestone Review on How Macrophages Affect Tumor Growth |
|
| Multivariate study of human CD4 T cell cytokine diversity : generation and association with breast cancer subtypes. |
|
| Neutrophil Heterogeneity in Cancer: From Biology to Therapies |
|
| A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage. |
|
| Partage des tâches entre différents sous-populations de cellules dendritiques plasmacytoïdes suite à une activation virale. |
|
| Pathophysiology of pDCs and gdT lymphocytes in melanoma context, and potential of their cross talk for the development of new therapies. |
|
| Plasmacytoid dendritic cells and immunosurveillance or immune escape in breast cancer : impact of activators versus inhibitors signals in tumoral microenvironment. |
|
| Plasmacytoid dendritic cells are dispensable for noninfectious intestinal IgA responses in vivo |
|
| Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis |
|
| Plasticité fonctionnelle des cellules NK induite par les facteurs cytokiniques : les rôles contrastés des Interleukines IL-33 et IL-35 |
|
| Pollution à l'ozone : maintien de la barrière pulmonaire via l'IL-33, implication des autres membres de la famille IL-1 et régulation cytokinique via AhR |
|
| Preclinical evaluation of the immunological effects of eribulin/cisplatin : rationale combination with anti-PD-L1 immunotherapy and TGF-β targeting in TNBC. |
|
| Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer |
|
| Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer |
|
| Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. |
|
| La résolution de l'inflammation comme approche thérapeutique innovante contre le cancer |
|
| Rôle de TLR7 dans la progression tumorale dans le cancer du poumon |
|
| Rôle de TRIM33 dans l'immunothérapie anti-tumorale radio-induite |
|
| Rôle des cellules dendritiques plasmocytoïdes dans la leucémie myélomonocytaire chronique |
|
| Role of the inflammasome and of Styk1 kinase in the regulation of cytotoxic lymphocytes. |
|
| Spécialisation fonctionnelle des cellules myéloïdes mononucléaires humaines dans l'induction des réponses T folliculaire helper |
|
| Study of the different susceptibility of primate lentiviruses to type I Interferons. |
|
| Study of the role of Interleukin-33 in NK cell activation and anti-tumour activity in breast cancer. |
|
| Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells |
|
| TLR9 transcriptional regulation in response to double-stranded DNA viruses. |
|
| The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development |
|
| Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment |
|
| Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN-{gamma} and Th1 chemokine production |
|
